Literature DB >> 1571428

Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited.

M C Rodriguez Barradas1, D M Musher, R J Hamill, M Dowell, J T Bagwell, C V Sanders.   

Abstract

Although AIDS was largely recognized and defined because of the increased presence of diseases that reflect deficiencies in cell-mediated immunity, susceptibility to common extracellular bacterial pathogens has also been shown to be increased. To our knowledge, adults with concurrent infection due to human immunodeficiency virus (HIV) and Streptococcus pneumoniae whose cases have been described to date have all had pneumococcal pneumonia and/or bacteremia. We describe five cases of HIV-infected patients who had unusual manifestations of pneumococcal infection, which include recurrent exudative pleural effusion, pyopneumothorax, purpura fulminans, mediastinitis with chest wall abscess, and multiple brain abscesses. Such complications of pneumococcal infection occurred more or less commonly in the preantibiotic era, but on the basis of our experience and an exhaustive literature search, these complications have been exceedingly rare in the past few decades. In four of our five patients, the unusual, complicated pneumococcal disease preceded and prompted a search for HIV infection. Because concurrent HIV infection increases the susceptibility to pneumococcal disease, other such cases are likely to be seen.

Entities:  

Mesh:

Year:  1992        PMID: 1571428     DOI: 10.1093/clinids/14.1.192

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Deep soft-tissue infections caused by Streptococcus pneumoniae.

Authors:  P Kragsbjerg; T Norén; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

2.  Mastoiditis, lymphoma, and AIDS.

Authors:  T Lowry; L Raja; A Verghese
Journal:  West J Med       Date:  1998-09

3.  Acute mediastinitis due to Rhodococcus equi in a patient with human immunodeficiency virus infection.

Authors:  J L Casado; A Antela; J A Sanchez; J M Hermida; M Meseguer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

4.  Validation of immune-complex enzyme immunoassays for diagnosis of pneumococcal pneumonia among adults in Kenya.

Authors:  J A Scott; A J Hall; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

5.  Pneumococcal parotitis and cervical lymph node abscesses in an HIV-infected patient.

Authors:  H J Stellbrink; H Albrecht; H Greten
Journal:  Clin Investig       Date:  1994-12

Review 6.  Human immunodeficiency virus infection and pneumothorax.

Authors:  Eirini Terzi; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Theodora Tsiouda; Athanasios Madesis; Theodoros Karaiskos; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

7.  Bacteremic pneumococcal cellulitis compared with bacteremic cellulitis caused by Staphylococcus aureus and Streptococcus pyogenes.

Authors:  O Capdevila; I Grau; M Vadillo; M Cisnal; R Pallares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-03       Impact factor: 3.267

8.  Streptococcus pneumoniae skin and soft tissue infections: characterization of causative strains and clinical illness.

Authors:  J M Garcia-Lechuz; O Cuevas; C Castellares; C Perez-Fernandez; E Cercenado; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03-20       Impact factor: 5.103

9.  Empyema thoracis in AIDS.

Authors:  R J Coker
Journal:  J R Soc Med       Date:  1994-02       Impact factor: 18.000

10.  Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival.

Authors:  Stephen B Gordon; Mas Chaponda; Amanda L Walsh; Christopher J M Whitty; Melita A Gordon; C Edward Machili; Charles F Gilks; Martin J Boeree; Sam Kampondeni; Robert C Read; Malcolm E Molyneux
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.